-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-24
EZ Cap Cy5 Firefly Luciferase mRNA combines a Cap1-capped, 5-moUTP modified mRNA with Firefly Luciferase and covalent Cy5 labeling. The dual readout separates intracellular RNA delivery from downstream protein expression for mRNA delivery and transfection, translation efficiency assay design, and bioluminescence imaging workflows.
-
GnRH Antagonist Design at Position 3
2026-08-24
Samant and colleagues investigated how replacing position 3 of degarelix with stereochemically distinct 3-(2-methoxy-5-pyridyl)-alanine residues affects GnRH receptor antagonism and in vivo duration. The study combined peptide synthesis, RP-HPLC separation, proteinase K digestion, receptor testing, and a castrated male rat assay to show that the D-configured analog retained potency, whereas both modified analogs were short-acting in vivo.
-
TNF-alpha recombinant murine protein Workflows
2026-08-23
Build reproducible murine cell-culture assays around a highly active trimeric cytokine for apoptosis, inflammation, and receptor-signaling studies. This workflow also shows how TNF-alpha treatment can serve as an orthogonal comparator when investigating the transcription-independent apoptotic response described in recent RNA Pol II research.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Signal to Mechanism
2026-08-22
ARCA Cy5 EGFP mRNA (5-moUTP) enables paired analysis of mRNA delivery, intracellular localization, and functional translation. This guide explains how to convert Cy5 and EGFP signals into mechanistic assay decisions within mammalian-cell and LNP workflows.
-
Z-WEHD-FMK for Caspase-1 and Pyroptosis Research
2026-08-22
Z-WEHD-FMK is a cell-permeable, irreversible inhibitor for dissecting inflammatory caspase activity in pyroptosis, infection, and Golgi-remodeling experiments. This guide translates the HOXC8–caspase-1 lung cancer findings into practical assay designs while distinguishing validated use cases from exploratory applications.
-
Flexible Phages for Rare-Cell Cancer Subtyping
2026-08-21
The reference study uses mechanically flexible M13 phage nanofibers to improve circulating tumor cell capture while limiting white blood cell adsorption. Its combination of affinity-based isolation and immunostaining differentiated breast cancer patients from healthy donors and supported breast cancer subtype classification.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-20
ARCA Cy5 EGFP mRNA (5-moUTP) provides a dual readout for distinguishing cellular delivery from productive translation. Its Cy5 label supports direct tracking, while EGFP expression helps benchmark delivery vehicles, formulation variables, and intracellular trafficking in mammalian cells.
-
URB597: From FAAH Assay to Pain Mechanism
2026-08-20
URB597 and KDS-4103 provide a selective way to interrogate FAAH-dependent anandamide biology. This article translates recent CBD pain research into a compartment-aware assay strategy for endocannabinoid, neuroinflammation, and affective-neuroscience studies.
-
Fluorouracil: From DNA Stress to Tumor Immunity
2026-08-19
Fluorouracil and 5-Fluorouracil are examined here through a mechanistic framework linking thymidylate synthase inhibition, DNA replication stress, and tumor-immune context. The article translates Wnt/β-catenin research into practical decisions for interpreting colon cancer research, breast cancer research, and combination assays.
-
Aprotinin: Protease Control for Better Assays
2026-08-19
Aprotinin, the bovine pancreatic trypsin inhibitor, can function as more than a protease blocker: it is a mechanistic control for separating proteolysis, inflammation, and transcriptional responses. This guide connects A2574 selection and handling with insights from an efficient GRO-seq workflow.
-
CBD, FAAH, and Affective Dimensions of Orofacial Pain
2026-08-18
This 2026 study shows that cannabidiol (CBD) can reduce inflammatory orofacial pain while also improving anxiety-like, depression-like, and cognitive outcomes in mice. Its multilevel design links peripheral FAAH and CB2-related signaling with central CB1, anandamide, and serotonergic mechanisms, providing a useful framework for dissecting sensory and affective pain biology.
-
MHY1485: Interpreting mTOR–Autophagy Experiments
2026-08-18
MHY1485 is an mTOR activator that helps dissect the relationship between mTOR signaling pathway activity and autophagic flux. This guide emphasizes causal assay design, interpretation of LC3-II accumulation, and applications spanning cancer biology, cell survival, and ovarian follicle development research.
-
Ganoderma Polysaccharide Enhances mRNA-LNP Efficacy
2026-08-17
A 2026 Pharmaceutics study identifies Ganoderma lucidum polysaccharide as an adjunct that may improve mRNA-LNP performance by reducing oxidative stress and modulating innate cellular responses. The formulation increased reporter protein expression in vitro and in vivo, while its translational relevance depends on further optimization, mechanistic validation, and testing across mRNA cargos and delivery contexts.
-
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-08-17
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka to compare acute and chronic sensitivity at multiple aquatic trophic levels. Their results identify microalgae as particularly sensitive test organisms and show why antibiotic residues from aquaculture require species-specific ecological assessment rather than reliance on a single indicator species.
-
PR-619: Practical DUB Inhibition Workflows
2026-08-16
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for mapping ubiquitinated-protein accumulation without directly blocking proteasomal catalytic activity. This guide translates its chemistry into reproducible workflows for ubiquitination pathway research, autophagy assays, cancer biology, and neurodegenerative disease models.